Local Antibiotics for Breast Implants

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Implant Complication, Implant Infection, Implant Site Infection, Implant Capsular Contracture, Implant Site Pocket Infection, Implant Expulsion, Antibiotic Side Effect

In brief

The BREAST-AB Trial is a multi-center, randomized, double blind, placebo-controlled trial investigating the efficacy of local application of gentamicin, vancomycin and cefazolin in decreasing all-cause implant explantation after breast reconstruction.

Key facts

Study ID
NCT04731025
Run by
Mikkel Herly
People needed
1003
Starts
2021-01-27
Expected to finish
2027-08-01
Last updated by the study team
2026-02-12

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.